196 completed, 47 terminated, 37 unknown, 19 recruiting. 320 Phase 2, 52 Phase 3, 42 Phase 1.
Follow Embolism and Thrombosis: new trials by email Literature Review of Embolism and Thrombosis trials Research Report on Embolism and Thrombosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| LVT DURATION: Pilot Study of Anticoagulation Duration for Left Ventricular Thrombus Continue rivaroxaban or apixaban or warfarin, Discontinue rivaroxaban or apixaban or warfarin - Left Ventricular Thrombus | Phase 2 | Not yet recruiting | Queen Mary University of London | 120 | 2026-12-01 | 2026-02-27 |
| A Study of LIQ861 (Inhaled Treprostinil) in Adults With Systemic Sclerosis Who Have Symptomatic Raynaud's Phenomenon Attacks LIQ861 (treprostinil) inhalation powder - Dose Titration Arm, LIQ861 (treprostinil) inhalation powder - fixed dose arm - Raynaud's Phenomenon Secondary to Systemic Sclerosis | Phase 2 | Not yet recruiting | Liquidia Technologies, Inc. | 75 | 2026-10-26 | 2026-08-07 |
| "IL-1β Blockade to Prevent Immunothrombosis in Recipients of a Pancreatic Organ" Anakinra 100Mg/0.67Ml Inj Syringe - Pancreatic Transplant | Phase 1 / Phase 2 | Recruiting | Nantes University Hospital | 15 | 2026-10-07 | 2026-10-13 |
| Vortosiran for VTE Prevention Vortosiran, Placebo - Venous Thromboembolism (VTE), Cancer | Phase 2 | Not yet recruiting | Ribocure Pharmaceuticals AB | 150 | 2026-10-01 | 2026-09-30 |
| Phase IIA Study of Belzutifan in EPAS1-, EGLN1-, or VHL-Mutant Erythrocytosis Belzutifan - Erythrocytosis, Pulmonary Hypertension | Phase 2 | Not yet recruiting | University of Utah | 16 | 2026-10-01 | 2026-10-26 |
| A First-in Human Study of ARD001 in Healthy Volunteers and People With Hemophilia A ARD001, Placebo - Hemophilia A, Healthy Adult Participants | Phase 1 / Phase 2 | Recruiting | Arditus Pte Ltd | 20 | 2026-08-19 | 2026-10-28 |
| Safety and Efficacy of a Single Dose of Gruticibart to Prevent CRT Placebo, Gruticibart, Ultrasound - Thrombosis | Phase 2 | Recruiting | OHSU Knight Cancer Institute | 90 | 2026-08-06 | 2026-08-31 |
| Comparative Evaluation of Sustained meChanical AsPiration Thrombectomy and no Thrombus Modification for Pre-stent Thrombus bUrden Reduction in Patients With Acute Myocardial Infarction Study: the CAPTURE AMI Study Sustained thrombectomy, Percutaneous Coronary Intervention - STEMI - ST Elevation Myocardial Infarction | Phase 2 / Phase 3 | Recruiting | Oxford University Hospitals NHS Trust | 60 | 2026-07-08 | 2026-07-10 |
| Effect of iNO in Patients With Submassive and Massive PE inhaled nitric oxide (iNO) - Pulmonary Embolism, Pulmonary Embolism Subacute Massive | Phase 2 | Withdrawn | University of California, Los Angeles | 2026-06-01 | 2026-03-18 | |
| Study of the SCD411 Prefilled Syringe for Treating Adults With Wet Age-Related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema, or Diabetic Retinopathy SCD411 0.05mL (2mg) - Neovascular (Wet) Age-Related Macular Degeneration, Retinal Vein Occlusion | Phase 2 | Completed | Sam Chun Dang Pharm. Co. Ltd. | 33 | 2026-05-13 | 2026-06-08 |
| Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Diabetic Retinopathy or Retinal Vein Occlusion ANXV - Non-Proliferative Diabetic Retinopathy, Retinal Vein Occlusion | Phase 2 | Recruiting | Annexin Pharmaceuticals AB | 12 | 2025-11-07 | 2025-12-02 |
| Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation REGN7508, REGN9933, Apixaban - Atrial Fibrillation (AF) | Phase 2 | Recruiting | Regeneron Pharmaceuticals | 1200 | 2025-10-20 | 2026-10-21 |
| Intra-Arterial Tenecteplase Following Endovascular Thrombectomy for Large Vessel Occlusion Stroke Intra-arterial Tenecteplase, Intra-arterial Saline - Acute Ischemic Stroke | Phase 2 | Enrolling by invitation | Wake Forest University Health Sciences | 40 | 2025-09-22 | 2026-09-25 |
| A Study to Compare the Efficacy and Safety of SRSD107 and Enoxaparin in Adult Subjects Undergoing TKA SRSD107, enoxaparin - Venous Thromboembolism | Phase 2 | Recruiting | Sirius Therapeutics Co., Ltd. | 450 | 2025-09-16 | 2026-01-15 |
| A Dose-masked Study of Intravitreal Remigromig (EYE103) in Participants With NVAMD or Macular Edema Following BRVO Remigromig, Aflibercept 2.0 mg - Neovascular Age-Related Macular Degeneration (NVAMD), Branch Retinal Vein Occlusion (BRVO) | Phase 2 | Recruiting | EyeBiotech Ltd. | 160 | 2025-09-12 | 2026-10-20 |
| A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy Low-dose ASA - Germ Cell Tumor, Testicular Cancer | Phase 2 | Recruiting | Wake Forest University Health Sciences | 35 | 2025-08-28 | 2026-07-24 |
| A Pilot Trial Comparing Full Dose Rivaroxaban to Prophylactic Dose Rivaroxaban in Patients With Superficial Vein Thrombosis in the Leg Full dose rivaroxaban, Low dose rivaroxaban, Placebo - SVT, Thrombosis | Phase 2 / Phase 3 | Recruiting | Ottawa Hospital Research Institute | 50 | 2025-08-06 | 2025-08-11 |
| Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery Tranexamic acid - Bleeding, Colorectal Disorders | Phase 2 | Recruiting | Kristen Ban | 394 | 2025-02-11 | 2026-05-28 |
| Anti-Xa Guided Dosing of Low Molecular Weight Heparin for Prevention of Venous Thromboembolism Following Traumatic Injury: a Multicentre Pilot Randomized Trial Anti-Xa Guided Dosing of Low Molecular Weight Heparin, Standard of Care Dosing - Venous Thromboembolism (VTE), Trauma Related Injuries | Phase 2 / Phase 3 | Unknown | Alexandre Tran | 150 | 2025-01-01 | 2024-10-28 |
| Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID) Inflammation (I), Inflammation (II), Inflammation (III) - Covid19 Virus Infection | Phase 1 / Phase 2 | Recruiting | All Natural Medicine Clinic, LLC | 100 | 2025-01-01 | 2025-02-19 |
Showing 20 of 320. Sign in to see all of them.
Thrombosis (89) · Venous Thromboembolism (83) · Venous Thrombosis (56) · Retinal Vein Occlusion (51) · Pulmonary Embolism (36) · Thromboembolism (27) · Raynaud Disease (23) · Macular Edema (20) · Hemorrhage (17) · Stroke (15) · Scleroderma, Systemic (12) · Ischemic Stroke (11) · Neoplasms (10) · Atrial Fibrillation (9) · COVID-19 (9)
Vascular Diseases (319) · Cardiovascular Diseases (316) · Thrombosis (130) · Thromboembolism (85) · Pathological Conditions, Signs and Symptoms (68) · Pathologic Processes (58) · Venous Thrombosis (54) · Eye Diseases (49) · Retinal Diseases (49) · Lung Diseases (44) · Respiratory Tract Diseases (44) · Embolism (35) · Nervous System Diseases (26) · Central Nervous System Diseases (24)
Enoxaparin (46) · Rivaroxaban (22) · apixaban (21) · Warfarin (20) · Aspirin (17) · Ranibizumab (14) · Dalteparin (12) · Heparin (11) · Dabigatran (9) · Fondaparinux (6) · edoxaban (6) · Bevacizumab (5) · Clopidogrel (5) · Heparin, Low-Molecular-Weight (5) · Tinzaparin (5)
Bayer (12) · Ottawa Hospital Research Institute (10) · Boehringer Ingelheim (9) · Astellas Pharma Inc (7) · Bristol-Myers Squibb (6) · Daiichi Sankyo (6) · University of Utah (6) · ARCA Biopharma, Inc. (5) · Pfizer (4) · Regeneron Pharmaceuticals (4) · Sanofi (4) · Shahid Beheshti University of Medical Sciences (4) · GlaxoSmithKline (3) · Hamilton Health Sciences Corporation (3) · M.D. Anderson Cancer Center (3)
United States (149) · Canada (55) · Germany (29) · France (28) · United Kingdom (26) · Italy (25) · Poland (25) · Austria (23) · Israel (23) · Spain (20) · Netherlands (18) · Russia (18) · Australia (16) · Denmark (16) · Japan (15)
Christopher Puccini, MD (3) · Peter A Campochiaro, MD (3) · Catherine A Cukras, M.D. (2) · Cecilia Becattini, MD (2) · Giancarlo Agnelli, MD (2) · Lawrence A. Yannuzzi, MD (2) · Marc Carrier, MD (2)
PMID 35244208, PMID 33086312, PMID 33337539, PMID 33502773, PMID 38189593, PMID 30633959, PMID 31420317, PMID 33779986, PMID 34622445, PMID 36413425, PMID 41218619, PMID 15141377, PMID 15893169, PMID 16458642, PMID 16531440, PMID 16598645, PMID 17353400, PMID 17599602, PMID 18082503, PMID 18088349, PMID 18178417, PMID 18195173, PMID 18307999, PMID 18360849, PMID 18402906, PMID 18621928, PMID 19187076, PMID 19194764, PMID 19268890, PMID 19365011, PMID 19640572, PMID 19734516, PMID 19737719, PMID 19833379, PMID 19854398, PMID 20212194, PMID 20212197, PMID 20442358, PMID 20448094, PMID 20627413, PMID 20886185, PMID 20937093, PMID 21106014, PMID 21600028, PMID 21621252, PMID 21664144, PMID 21680946, PMID 21700934, PMID 21794899, PMID 21868066
2014 (4), 2016 (3), 2005 (2), 2008 (2), 2017 (2), 2018 (2), 2019 (2), 2023 (2), 1UG1EY026876-01A1 (1), 1UG1EY028517-01 (1), 1UM1HL113203-01A1 (1), 2004 (1), 2009 (1), 2015 (1), P30CA015704 (1)